Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DMT Withdrawal in Inactive SPMS Patients > 50 Years
NCT03653273Phase 3Active, not recruiting
- Sponsor
- CHU Rennes
- Start
- Jan 2019
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Secondary Progressive Multiple Sclerosis (SPMS) (2 arms), sponsored by CHU Rennes. Primary endpoint: Disability progression measured by EDSS at 24 months. Started Jan 2019; status: active, not recruiting.
02
Conditions
Secondary Progressive Multiple Sclerosis (SPMS)
Beyond the preview
Go deeper on NCT03653273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03653273.